Modular nanorobot from University of Basel cut cancer cell viability to 16% by synthesizing drugs directly on cell surfaces ...

A team at the University of Basel, Switzerland, has developed a versatile nanorobot with propulsion and payload modules. The ...

Re-VOLVE: Phase II clinical trial in women with ovarian cancer progressing post-PARP inhibitor with treatment adapted to real-time assessment of evolving genomic resistance. Circulating tumor DNA ...

Endometrial cancer remains a major gynecological malignancy with a rising incidence and limited treatment options for advanced cases. Our previous study demonstrated that the Q7 anticancer peptide ...

Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...

MSCs possess tumor-homing abilities and exhibit low immunogenicity. MSCs can be engineered to deliver therapeutic agents, such as proteins, microRNAs, and drugs, directly to the tumor microenvironment ...

A cell is fundamentally a container—a vessel that encapsulates life at the most basic level. Many biologists believe encapsulation of chemicals may have been necessary for evolution to gain traction.